Journal of Natural Products · 2009 · 51 citations · 30 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionMedicinal PlantsStructure-activity Relationship AnalysisAdvanced Glycation End ProductsAldose Reductase TargetsMedicinal Aromatic PlantsMonoterpene BiosynthesisPhenylpropanoid Glycosides
The methanol extract of Moutan cortex (Paeonia suffruticosa) afforded two new compounds, 8-O-benzoylpaeonidanin (1) and 5-hydroxy-3S-hydroxymethyl-6-methyl-2,3-dihydrobenzofuran (2), in addition to 4-O-butylpaeoniflorin (3) as an artifact of the separation, seven monoterpene glycosides (4-10), two monoterpenes (11, 12), four acetophenones (13-16), and two triterpenes (17, 18). The structures of the compounds were determined by spectroscopic methods, and the compounds were evaluated for inhibitory effects against rat lens aldose reductase (RLAR) and advanced glycation end-product (AGEs) formation. Compounds 17 and 18 showed the most potent inhibitory activity against RLAR, with IC(50) values of 11.4 and 28.8 microM, respectively. Compounds 3 and 6 also inhibited RLAR with IC(50) values of 36.2 and 44.6 microM, respectively. The positive control, 3,3-tetramethyleneglutamic acid, had an IC(50) value of 31.8 microM. Compounds 3 and 6 inhibited AGE formation with IC(50) values of 10.8 and 11.3 microM, respectively. Compound 2 had an IC(50) value of 177.0 microM, whereas the positive control, aminoguanidine, had an IC(50) value of 1026.8 microM.
30
Biochemistry and molecular cell biology of diabetic complications
Michael Brownlee · Nature · 2001 · 9K citations
Mechanisms initiating cataract formation. Proctor Lecture.
Jin H. Kinoshita · PubMed · 1974 · 317 citations
Chemical studies on the oriental plant drugs—XXXIII
M. Kaneda, Yöichi Iitaka, Shoji Shibata · Tetrahedron · 1972 · 155 citations